PACB vs XRAY · rev $76.2M vs rev $1.78B
Pacific Biosciences of California (PACB) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported PACB revenue for 2026-06-30 was $76.2M. Net income was -$53.0M. PACB currently screens at market cap $387.1M.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
PACB currently screens at market cap $387.1M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the PACB and XRAY stock pages for the full models.
Not investment advice.